EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Efficacy of reconstituted intravenous fentanyl to sublingual solution versus oral morphine syrup for breakthrough pain among patients with chronic gynecologic cancer pain: A randomized, double‐blind, placebo‐controlled trial

Thitirath Thantiprechapong, Thanvarat Tilagul, Vasin Vasikasin iD

Journal of Obstetrics and Gynaecology Research · 2023

DOI: 10.1111/jog.15674 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2023. Verfasst von Thitirath Thantiprechapong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Rajavithi Hospital, Bangkok, Thailand. Hauptthemen laut MEDLINE: Analgesics, Opioid, Breakthrough Pain, Cancer Pain, Fentanyl. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: The Rajavithi Research Management Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid‐acting fentanyl formulations are superior to oral morphine (OM) syrup in controlling breakthrough pain among patients with cancer, but they are expensive and unavailable in many countries.

Objective

To evaluate the efficacy of reconstituted intravenous fentanyl to sublingual solution (IFS) in relieving breakthrough pain as compared with OM.

Methods

In this randomized, double‐blind, double‐dummy, placebo‐controlled trial, patients with gynecologic cancer aged ≥18 years experiencing chronic cancer pain with breakthrough pain were enrolled. Patients were randomly allocated (1:1) to receive either 50 μg IFS or 5 mg OM. Pain intensity level was assessed at 5, 15, 30, 45, 60, and 120 min after treatment. The primary outcome was the reduction in pain intensity at 15 min in the intention‐to‐treat population ( ClinicalTrials.gov , NCT05037539).

Results

Between June 15, 2021 and December 30, 2021, 40 participants were equally and randomly assigned to receive IFS or OM. The primary outcome was significantly higher in the IFS group (4.25 vs. 1.05, p < 0.0001). The secondary outcomes also showed higher reduction in pain intensity at 5 min in the IFS group. Subsequent breakthrough pain did not differ between the two groups. However, the reduction in pain was lower in the IFS group at 45, 60, and 120 min, where pain was classified as mild. No severe adverse effects were observed in both groups. Burning sensation without noticeable lesion was found in 20% of the IFS group.

Conclusion

IFS can reduce early breakthrough pain. IFS may be considered for breakthrough pain when rapid‐acting fentanyl formulations are unavailable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidBreakthrough PainCancer PainFentanylGenital Neoplasms, FemaleMorphineAdolescentAdultFemaleHumansDouble-Blind MethodTreatment OutcomeAdministration, Sublingual

Stichwörter der Autor:innen

breakthrough paincancer painfentanylmorphinesublingual administration

Substanzen

Analgesics, OpioidFentanylMorphine

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Rajavithi Hospital, Bangkok, Thailand.
  • College of Medicine, Rangsit University, Bangkok, Thailand.
  • Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.

ORCID-Profile: Vasin Vasikasin

Förderung

  • The Rajavithi Research Management Fund

Zitieren

APA

Thantiprechapong, T., Tilagul, T., & Vasikasin, V. (2023). Efficacy of reconstituted intravenous fentanyl to sublingual solution versus oral morphine syrup for breakthrough pain among patients with chronic gynecologic cancer pain: A randomized, double‐blind, placebo‐controlled trial. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.15674

Vancouver

Thantiprechapong T, Tilagul T, Vasikasin V. Efficacy of reconstituted intravenous fentanyl to sublingual solution versus oral morphine syrup for breakthrough pain among patients with chronic gynecologic cancer pain: A randomized, double‐blind, placebo‐controlled trial. Journal of Obstetrics and Gynaecology Research. 2023. doi:10.1111/jog.15674

BibTeX
@article{Thantiprechapong2023,
  author = {Thantiprechapong, Thitirath and Tilagul, Thanvarat and Vasikasin, Vasin},
  title = {Efficacy of reconstituted intravenous fentanyl to sublingual solution versus oral morphine syrup for breakthrough pain among patients with chronic gynecologic cancer pain: A randomized, double‐blind, placebo‐controlled trial},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2023},
  doi = {10.1111/jog.15674}
}
Kostenlos starten →